11 h. ago Alzheimer's drug rejected for NHS use can 'slow disease' by 8 years

The spending watchdog deemed the drug's benefits 'too small' to justify the cost of making it available on the NHS

Events

55 h. ago Weight loss jab could be used to slow progression of Alzheimer’s disease in major breakthrough

Liraglutide, sold under the brand name Saxenda, is already prescribed on the NHS as a weight loss medication

Politics

6 d. ago NHS advisors set to reject prostate screening programme for most men

Government advisors are today expected to reject calls for a widespread prostate cancer screening programme in a major blow to British men.

Politics

1 week ago Weight loss jabs do not slow Alzheimer's disease as hoped, causing firm's share prices to plummet

Novo Nordisk had hoped to repurpose semaglutide - the active ingredient in its Wegovy and Ozempic jabs - as a groundbreaking dementia treatment after seeing early encouraging signs.

Economics

1 week ago European defence company shares fall amid Ukraine peace talk hopes; Novo Nordisk reports Ozempic fails to help with Alzheimer’s – as it happened

Rolling coverage of the latest economic and financial news, as Novo Nordisk finds its semaglutide drug fails to help in Alzheimer’s treatmentGerman business morale has unexpectedly fallen this month, as companies lose hope on a recovery of the German economy following two years of contraction.The Ifo institute has reported that its business climate index fell to 88.1 in November from 88.4 in October, weaker than expected. It’s a blow to German chancellor Friedrich Merz’s efforts to revive growth through a major spending package.“Companies have little faith that a recovery is coming anytime soon.”Like U2 sang almost 40 years ago: the German economy still hasn’t found what it’s looking for.The year 2025 has been another year of hope and disappointed optimism. A year which saw excitement and enthusiasm sparked by Germany’s unprecedented fiscal policy U-turn and its decision to invest significantly in infrastructure and defence this spring. But also a year that brought a rude awakening ...

Events

1 week ago European defence company shares fall amid Ukraine peace talk hopes; Novo Nordisk reports Ozempic fails to help with Alzheimer’s – business live

Rolling coverage of the latest economic and financial news, as Novo Nordisk finds its semaglutide drug fails to help in Alzheimer’s treatmentGerman business morale has unexpectedly fallen this month, as companies lose hope on a recovery of the German economy following two years of contraction.The Ifo institute has reported that its business climate index fell to 88.1 in November from 88.4 in October, weaker than expected. It’s a blow to German chancellor Friedrich Merz’s efforts to revive growth through a major spending package.“Companies have little faith that a recovery is coming anytime soon.”Like U2 sang almost 40 years ago: the German economy still hasn’t found what it’s looking for.The year 2025 has been another year of hope and disappointed optimism. A year which saw excitement and enthusiasm sparked by Germany’s unprecedented fiscal policy U-turn and its decision to invest significantly in infrastructure and defence this spring. But also a year that brought a rude awakening ...

Events

1 week ago Novo Nordisk shares slump after drug failure in Alzheimer’s trial

Outcome is blow to one of Europe’s largest listed companies

Events

2 w. ago Could Viagra, the shingles vaccine and an MND drug halt Alzheimer's?

A panel of academics, doctors and patients examined 80 existing treatments to identify those mostly likely to help tackle Alzheimer's - for which there is currently no cure.

Events

3 w. ago New drug could 'slow progression' of motor neurone disease and offer 'real hope'

The discovery offers hope of substantially slowing the progression of "one of the cruellest diseases"

Events

4 w. ago Wes Streeting accuses junior doctors of 'holding the country to ransom' in bitter pay dispute after they reject inflation

The Health Secretary hit out at the British Medical Association (BMA) ahead of their planned five-day strikes later this month.

Economics